The Association Between Serum α 1‐Acid Glycoprotein and Obesity and Abdominal Obesity in Women: A Cross‐Sectional Study Based on NHANES Data From 2015 to 2018
Open Access
- 30 January 2026
- journal article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2026 (1)
Abstract
Background: Obesity and abdominal obesity are major public health issues closely related to metabolic diseases. Serum α 1‐acid glycoprotein (SSAGP), an acute‐phase reactant influenced by inflammation and metabolic status, has an unclear relationship with obesity and abdominal obesity. This study investigates this association in women. Methods: Using cross‐sectional data from NHANES (2015–2018), 2219 adult women were divided into three groups based on SSAGP levels (low, medium, and high). Multiple regression analyses assessed the relationship between SSAGP and BMI, waist circumference, obesity (BMI ≥ 30 kg/m 2 ), and abdominal obesity (waist circumference ≥ 90 cm). Threshold and interaction analyses were also conducted. Results: As SSAGP levels increased, BMI, waist circumference, fasting blood glucose, insulin, and hs‐CRP levels rose significantly ( p < 0.001), while HDL levels decreased ( p < 0.001). SSAGP was positively correlated with BMI, waist circumference, obesity, and abdominal obesity ( p < 0.0001). After adjusting for confounders, a one‐unit increase in SSAGP was associated with a 4.42 increase in BMI (95% CI: 3.08, 5.76), a 12.18 cm increase in waist circumference (95% CI: 9.22, 15.14), a 3.63‐fold increase in obesity risk (95% CI: 1.96, 6.72), and a 10.75‐fold increase in abdominal obesity risk (95% CI: 4.85, 23.85). Threshold effect analysis showed an inflection point ( K = 1.2), with SSAGP having a stronger promoting effect below this point and an inhibitory effect above it ( p < 0.001). Educational level significantly influenced the SSAGP‐obesity relationship ( p = 0.0096). Conclusion: SSAGP levels are significantly associated with obesity and abdominal obesity in women, with educational level playing a modulatory role. SSAGP may serve as a potential biomarker for obesity risk. Future studies should explore the causal relationships and underlying mechanisms.Keywords
Funding Information
- Medical Scientific Research Foundation of Zhejiang Province, China (2023ZL700)
This publication has 47 references indexed in Scilit:
- The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus.2004
- α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating propertiesCytokine & Growth Factor Reviews, 2003
- Fucosylation of α1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritisClinica Chimica Acta, 2002
- Alpha-1-acid glycoproteinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Changes of α1-acid glycoprotein microheterogeneity in acute inflammation stages analyzed by isoelectric focusing using serum obtained postoperativelyElectrophoresis, 2000
- Effects of alpha 1-acid glycoprotein on tissue factor expression and tumor necrosis factor secretion in human monocytesImmunopharmacology, 1996
- Cigarette smoking, dietary intake, and physical activity: effects on body fat distribution—the Normative Aging StudyThe American Journal of Clinical Nutrition, 1991
- Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.Journal of Clinical Investigation, 1985
- MONITORING THE THERAPY OF LUNG-CANCER WITH ALPHA-1-ACID GLYCOPROTEIN1984
- Serum α-1-acid glycoprotein as an index of dissemination in breast cancerBritish Journal of Surgery, 1975